A phase 2 study to evaluate safety and efficacy of laparoscopic sleeve gastrectomy with duodenojejunal bypass for obesity with diabetes mellitus

A phase 2 study to evaluate safety and efficacy of laparoscopic sleeve gastrectomy with duodenojejunal bypass for obesity with diabetes mellitus - A phase 2 study of laparoscopic sleeve gastrectomy with duodenojejunal bypass

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035537

Enrollment

Registered

2019-01-15

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid obesity with diabetes mellitus

Interventions

Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 BMI: 35Kg/m2 or more 2 Duration of diabetes care: >> 6 months 3 ASA-PS: << Class 3

Exclusion criteria

Exclusion criteria: Severe organ dysfunction

Design outcomes

Primary

Measure	Time frame
Remission rate of diabetes mellitus	—

Secondary

Measure	Time frame
Surgical morbidity	—

Countries

Japan

Contacts

Public ContactKentaro Inoue

Kansai Medical University Hospital Gastrointestinal surgery

inoueke@hirakata.kmu.ac.jp81728040101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026